Our tools can support Alzheimer researchers with their compounds and solutions — we have reached out to the Cell Reports Medicine team behind the 2025 P7C3-A20 / NAD+ reversal study (Pieper lab, Case Western Reserve / Harrington Discovery Institute) to offer that support, and welcome similar conversations with other groups. A European computational-biology team with 22+ peer-reviewed biology papers, including 7 Alzheimer-specific papers at ICLR 2026 across genomics, drug-discovery, and biomedical-reasoning workshops (Gen², MLGenX, World Models for AD treatment). To foundations and associations: our 37-module computational platform is made available to the researchers you fund, under partnership terms. To research labs: bring your target, your compound, your hypothesis — use our computational tools.
We are a self-funded computational-biology team accelerating Alzheimer's research. Foundations and associations are our most powerful allies — here is how we can build something meaningful together.
Your network is our most valuable resource. By amplifying our work, you directly accelerate Alzheimer's drug discovery.
You're not a research lab. You're a fundraising organization competing for donor dollars. Here's what a partnership with Reversal does for your foundation — not for researchers, for your organization.
We are flexible on structure. What matters is alignment on mission and impact.
enrique.zueco@aixcbio.com · We respond within 48 hours
Our partner lab program provides shared compute, co-authorship opportunities, and full platform access for Alzheimer's research teams.
Access our GPU infrastructure for molecular docking, MD simulation, and virtual screening at no cost.
Joint publications on results generated using our platform. We contribute computational methodology; you contribute domain expertise.
Complete access to all 37+ modules, documentation, and training materials. Priority support from our development team.
Our platform is designed to integrate seamlessly with the computational tools your lab already uses. Standard chemical file formats (SDF, MOL2, PDB, SMILES), Python 3.9+ API.
For pharmaceutical companies and large research organizations, our commercial arm AIXC AIXC Bio offers full-service computational drug discovery with dedicated support and regulatory documentation.
Tell us about your target, your lab, and your research goals. We will set up a call to discuss how our platform can accelerate your work.